Esra Meidan, MD
Rheumatologist, Rheumatology Program
Instructor of Pediatrics, Harvard Medical School
Image
Esra Meidan, MD
Rheumatologist, Rheumatology Program
Instructor of Pediatrics, Harvard Medical School
Medical Services
Languages
English
Turkish
Education
Medical School
Istanbul University, Cerrahpasa Medical School
2005
Istanbul
Turkey
Internship
Boston Children's Hospital
2011
Boston
MA
Residency
Boston Children's Hospital
2013
Boston
MA
Fellowship
Boston Children's Hospital
2016
Boston
MA
Certifications
American Board of Pediatrics (General)
American Board of Pediatrics (Rheumatology)
Publications
Sex Differences in B Cells From the Joints of Children With Oligoarticular Juvenile Idiopathic Arthritis. View Abstract
Real-world application of the pediatric Glucocorticoid Toxicity Index in childhood-onset lupus. View Abstract
Elevation of IL-17 Cytokines Distinguishes Kawasaki Disease From Other Pediatric Inflammatory Disorders. View Abstract
Type I interferon signature and cycling lymphocytes in macrophage activation syndrome. View Abstract
Development of a Screening Algorithm for Lung Disease in Systemic Juvenile Idiopathic Arthritis. View Abstract
Incidence and Risk Factors for Eosinophilia and Lung Disease in Biologic-Exposed Children With Systemic Juvenile Idiopathic Arthritis. View Abstract
Disordered T cell-B cell interactions in autoantibody-positive inflammatory arthritis. View Abstract
An Evidence-Based Guideline Improves Outcomes for Patients With Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome. View Abstract
Proteomics based markers of clinical pain severity in juvenile idiopathic arthritis. View Abstract
Th1 polarization defines the synovial fluid T cell compartment in oligoarticular juvenile idiopathic arthritis. View Abstract
Differences in rituximab use between pediatric rheumatologists and nephrologists for the treatment of refractory lupus nephritis and renal flare in childhood-onset SLE. View Abstract
Coronary artery aneurysms in children is not always Kawasaki disease: a case report on Takayasu arteritis. View Abstract
A multidisciplinary assessment of pain in juvenile idiopathic arthritis. View Abstract
Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children. View Abstract
Th17 reprogramming of T cells in systemic juvenile idiopathic arthritis. View Abstract
Serine/threonine phosphatase PP2A is essential for optimal B cell function. View Abstract
Adenosine deaminase 2 as a biomarker of macrophage activation syndrome in systemic juvenile idiopathic arthritis. View Abstract
PP2A enables IL-2 signaling by preserving IL-2Rß chain expression during Treg development. View Abstract
Pathogenesis of Human Systemic Lupus Erythematosus: A Cellular Perspective. View Abstract
Phosphatase PP2A is requisite for the function of regulatory T cells. View Abstract
TRIF signaling is essential for TLR4-driven IgE class switching. View Abstract
Toll-like receptor 9, transmembrane activator and calcium-modulating cyclophilin ligand interactor, and CD40 synergize in causing B-cell activation. View Abstract
Cdc42 interacting protein 4 (CIP4) is essential for integrin-dependent T-cell trafficking. View Abstract
The murine equivalent of the A181E TACI mutation associated with common variable immunodeficiency severely impairs B-cell function. View Abstract
Transmembrane activator, calcium modulator, and cyclophilin ligand interactor drives plasma cell differentiation in LPS-activated B cells. View Abstract
Transmembrane activator and calcium-modulator and cyclophilin ligand interactor mutations in common variable immunodeficiency. View Abstract
Primary immune deficiencies with aberrant IgE production. View Abstract
Transmembrane activator and calcium modulator and cyclophilin ligand interactor enhances CD40-driven plasma cell differentiation. View Abstract
Locations